Vanguard’s strategic alliance with Arbro is expected to ensure delivery of quality products at affordable prices.
Vanguard said that it has performed a market price analysis of Arbro’s drugs in Brazil, Peru, and Paraguay and has found their prices to be significantly lower than recent tenders granting it a huge opportunity in these countries.